4 results match your criteria: "Marworth Treatment Center[Affiliation]"
Rise and regional disparities in buprenorphine utilization in the United States.
Pharmacoepidemiol Drug Saf
June 2020
Department of Medical Education, Geisinger Commonwealth School of Medicine, Scranton, Pennsylvania, USA.
Purpose: Buprenorphine is an opioid partial agonist used to treat opioid use disorder. While several policy changes have attempted to increase buprenorphine availability, access remains well below optimal levels. This study characterized how buprenorphine utilization in the United States has changed over time and whether there are regional disparities in distribution of the medication.
View Article and Find Full Text PDFIncreasing heroin, cocaine, and buprenorphine arrests reported to the Maine Diversion Alert Program.
Forensic Sci Int
October 2019
Geisinger Commonwealth School of Medicine, Scranton, PA 18509, USA; Center for Pharmacy Innovations and Outcomes, Forty Fort, PA 18704, USA. Electronic address:
Background: The opioid overdose crisis is especially pronounced in Maine. The Diversion Alert Program (DAP) was developed to combat illicit drug use and prescription drug diversion by facilitating communication between law enforcement and health care providers with the goal of limiting drug-related harms and criminal behaviors. Our objectives in this report were to analyze 2014-2017 DAP for: (1) trends in drug arrests and, (2) differences in arrests by offense, demographics (sex and age) and by region.
View Article and Find Full Text PDFControlled Substances and Prescribers.
J Addict Med
August 2016
Chillicothe VA Medical Center, Chillicothe, OH (DTB); Addiction Medicine, Marworth Treatment Center, Waverly, PA (DW).
The deception of alcohol.
JAAPA
June 2014
Caitlyn Morgigno practices in the Marworth Treatment Center, part of the Geisinger Health System, in Waverly, Pa. The author has disclosed no potential conflicts of interest, financial or otherwise.